“…Independent targeting of TMV's tyrosines and glutamates allows heterologous functionalization of their distinct surfaces. Given TMV's potential drug delivery and imaging applications, bioconjugated molecules include fluorescent dyes, MRI contrast agents, poly(ethylene glycol) (PEG) to tune circulatory clearance rates, carbohydrates, folic acid, and peptides (cRGD) to assist endocytosis, and pharmaceutical agents including doxorubicin and cisplatin . Additionally, the negative charges of the inner channel glutamates (E97 and E106) are sufficient for non‐covalent loading and retention of ≈800 molecules/virion of a triply cationic porphyrin‐based photosensitizer or ≈2000 molecules/virion (≈1 molecule/CP) of the doubly cationic chemotherapeutic candidate phenanthriplatin with subsequent release in acidic environments …”